Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 18.41
-0.09 (-0.49%)
Sep 3, 2025, 11:44 AM HKT
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 57.73 billion as of September 2, 2025. Its market cap has decreased by -7.41% in one year.
Market Cap
57.73B
Enterprise Value
162.08B
Revenue
630.98B
Ranking
n/a
PE Ratio
7.71
Stock Price
18.41
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 57.73B, an increase of 42.82%. That is a compound annual growth rate of 2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 57.73B | -13.15% |
| Dec 31, 2024 | 66.47B | 4.16% |
| Dec 29, 2023 | 63.82B | 3.07% |
| Dec 30, 2022 | 61.91B | 16.98% |
| Dec 31, 2021 | 52.93B | -10.07% |
| Dec 31, 2020 | 58.86B | -30.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 262.49B |
| Hansoh Pharmaceutical Group Company | 218.06B |
| JD Health International | 201.05B |
| Innovent Biologics | 165.88B |
| Sino Biopharmaceutical | 145.04B |
| Akeso | 139.76B |
| WuXi Biologics | 135.14B |
| CSPC Pharmaceutical Group | 115.13B |